Because lack the evidence to provide a reliable conclusion in a single study, we conducted a meta-analysis on these eligible studies, to evaluate the strength relationship between the iNOS gene polymorphism and risk for cancer, which would have a much greater possibility of reaching reasonably strong conclusions. The gene discussed is NOS2; the disease is cancer.